Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


2 BMC Gastroenterol
1 Eur J Gastroenterol Hepatol
3 Hepatology
1 J Hepatol
2 J Infect Dis
1 J Med Virol
2 J Viral Hepat
1 J Virol
2 PLoS One
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    BMC Gastroenterol

  1. CHEN S, Huang H, Huang W
    Correction to: A noninvasive model to predict liver histology for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase < 2 upper limit of normal.
    BMC Gastroenterol. 2021;21:109.

  2. ZHENG L, Liu Y, Shang Y, Han Z, et al
    Clinical characteristics and treatment outcomes of acute severe autoimmune hepatitis.
    BMC Gastroenterol. 2021;21:93.
    PubMed         Abstract available

    Eur J Gastroenterol Hepatol

  3. OZNUR M, Topcu B, Celikkol A
    Predictive value of noninvasive indices in chronic hepatitis B virus-related fibrosis.
    Eur J Gastroenterol Hepatol. 2021;33:577-582.
    PubMed         Abstract available


  4. PONZIANI FR, Gasbarrini A, Pompili M
    Letter to the Editor. Restructuring the Gut Microbiota of Cirrhotic Patients after HCV Eradication: a Matter of Time?
    Hepatology. 2021 Mar 5. doi: 10.1002/hep.31784.
    PubMed         Abstract available

  5. COCHARD J, Bull-Maurer A, Tauber C, Burlaud-Gaillard J, et al
    Differentiated cells in prolonged hypoxia produce highly infectious native-like hepatitis C virus particles.
    Hepatology. 2021 Mar 4. doi: 10.1002/hep.31788.
    PubMed         Abstract available

  6. WONG RJ, Brosgart CL, Welch S, Block T, et al
    An Updated Assessment of Chronic Hepatitis B Prevalence Among Foreign-Born Persons Living in the United States.
    Hepatology. 2021 Mar 3. doi: 10.1002/hep.31782.
    PubMed         Abstract available

    J Hepatol

  7. MARTIN MT, Patel S, Kulik L, Chan C, et al
    Glecaprevir/pibrentasvir + sofosbuvir + ribavirin offers high cure rate for hepatitis C virus retreatment in real-world settings.
    J Hepatol. 2021 Feb 27. pii: S0168-8278(21)00158.

    J Infect Dis

  8. CHANG WY, Chiu YC, Chiu FW, Hsu YC, et al
    High Risk of clinical relapse in HBV-infected patients after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy.
    J Infect Dis. 2020 May 12. pii: 5836326. doi: 10.1093.
    PubMed         Abstract available

  9. ARANDAY-CORTES E, McClure CP, Davis C, Irving WL, et al
    Real-World Outcomes of DAA Treatment and Retreatment in UK-based Patients Infected with HCV Genotypes/Subtypes Endemic in Africa.
    J Infect Dis. 2021 Mar 1. pii: 6154708. doi: 10.1093.
    PubMed         Abstract available

    J Med Virol

  10. HU Q, Wang Q, Zhang Y, Tao S, et al
    Baseline serum exosome-derived miRNAs predict HBeAg seroconversion in chronic hepatitis B patients treated with peginterferon.
    J Med Virol. 2021 Mar 5. doi: 10.1002/jmv.26916.
    PubMed         Abstract available

    J Viral Hepat

  11. DOLMAN GE, Koffas A, Phipps E, Kennedy PTF, et al
    Clinical and occupational health management of healthcare workers living with chronic hepatitis B: UK policy and international comparisons.
    J Viral Hepat. 2021 Mar 4. doi: 10.1111/jvh.13494.
    PubMed         Abstract available

  12. XIAO Y, Wallace J, Thompson A, Hellard M, et al
    A qualitative exploration of enablers for hepatitis B clinical management among ethnic Chinese in Australia.
    J Viral Hepat. 2021 Mar 4. doi: 10.1111/jvh.13495.
    PubMed         Abstract available

    J Virol

  13. TEGTMEYER B, Vieyres G, Todt D, Lauber C, et al
    Initial HCV infection of adult hepatocytes triggers a temporally structured transcriptional program containing diverse pro- and anti-viral elements.
    J Virol. 2021 Mar 3. pii: JVI.00245-21. doi: 10.1128/JVI.00245.
    PubMed         Abstract available

    PLoS One

  14. CHARATCHAROENWITTHAYA P, Sukonrut K, Korpraphong P, Pongpaibul A, et al
    Diffusion-weighted magnetic resonance imaging for the assessment of liver fibrosis in chronic viral hepatitis.
    PLoS One. 2021;16:e0248024.
    PubMed         Abstract available

  15. HO H, Janjua NZ, McGrail KM, Harrison M, et al
    The impact of public coverage of newer hepatitis C medications on utilization, adherence, and costs in British Columbia.
    PLoS One. 2021;16:e0247843.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  16. KIM GW, Siddiqui A
    N6-methyladenosine modification of HCV RNA genome regulates cap-independent IRES-mediated translation via YTHDC2 recognition.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.